Korea inks MoU with US for collaborative vaccine research

The International Vaccine Institute (IVI) in South Korea, the Texas Children’s Hospital Center for Vaccine Develop...

September 30, 2021 | Thursday | News
China focuses on mRNA vaccine R&D and industrialisation

Jiangsu Recbio Technology and Shenzhen Rhegen Biotechnology have recently signed a joint venture agreement to establish ...

September 30, 2021 | Thursday | News
Serum Institute, Novavax submit COVID-19 vaccine emergency use listing to WHO

Indian vaccine manufacturer Serum Institute of India (SII) and its US-based partner Novavax, have announced a regulatory...

September 24, 2021 | Friday | News
Vietnam signs MoU with India for COVID-19 vaccine

Translational Health Science and Technology Institute (THSTI), Department of Biotechnology (DBT), Government of India ha...

September 24, 2021 | Friday | News
Singapore receives extra 101,000 doses of SINOVAC COVID-19 vaccines (CoronaVac®)

SINOVAC Biotech Ltd. is supplying 101,000 doses of the inactivated COVID-19 vaccine (CoronaVac®), to Singapore. ...

September 15, 2021 | Wednesday | News
UK launches antibody surveillance program to analyze COVID-19 infection/vaccination

UK Health Security Agency to launch UK-wide antibody surveillance programme for the general public for the first time H...

September 14, 2021 | Tuesday | News
Everest Medicines to advance mRNA vaccines & therapies in Asia emerging markets

China-based startup Everest Medicines has inked two separate definitive agreements with Canadian biotech firm Provi...

September 14, 2021 | Tuesday | News
China's Clover Biopharma to launch protein-based COVID-19 vaccine by 2021-end

China-based Clover Biopharmaceuticals has announced that its wholly-owned subsidiary, Zhejiang Clover Biopharmaceut...

September 13, 2021 | Monday | News
World's first Nano cellular broad-spectrum COVID-19 vaccine developing in Australia

EnGeneIC Limited, an Australian, Sydney-based biotechnology company, has developed a globally unique nano cellular techn...

September 8, 2021 | Wednesday | News
Japan buys 150 M doses of Novavax COVID-19 vaccine

Takeda Pharmaceutical has announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MH...

September 8, 2021 | Wednesday | News
The EU secures 200 million COVID-19 vaccine doses by AstraZeneca

The EU and AstraZeneca have reached an agreement that will secure the delivery of the remaining COVID-19 vaccine doses t...

September 7, 2021 | Tuesday | News
Vax cocktail endgame against COVID-19

Vaccine mixing, which began unintentionally, is now gaining traction. There is a significant interest in mixing two diff...

September 6, 2021 | Monday | Opinion
Singapore recommends additional dose of mRNA COVID-19 vaccine for seniors, immunocompromised

The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore has been closely reviewing the data regarding the need...

September 6, 2021 | Monday | News
India approves Ph III trials of Biological E's COVID-19 vaccine candidate

Indian firm Biological E. has received Drugs Controller General of India (DCGI) approval for conducting Phase III Compar...

September 3, 2021 | Friday | News
Korea's CancerRop becomes largest shareholder of cancer vaccine firm Oxford Vacmedix

South Korea-based CancerRop has announced a jump start in the global vaccine hub for COVID-19 mRNA (messenger ribonuclei...

August 31, 2021 | Tuesday | News
Bharat Biotech announces global Chikungunya vaccine Ph II/III trial in Costa Rica

South Korea-based International Vaccine Institute (IVI) has announced that the first participant has received Indian fir...

August 25, 2021 | Wednesday | News
India's first mRNA-based vaccine moves into Phase II/III trial

Indian firm Gennova Biopharmaceuticals working on the nation's first mRNA-based COVID-19 vaccine, submitted the interim ...

August 24, 2021 | Tuesday | News
Pfizer-BioNTech COVID-19 vaccine receives full approval from USFDA

The U.S. Food and Drug Administration has approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-...

August 24, 2021 | Tuesday | News